Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diamyd intralymphatic therapy plus oral vitamin D in recent-onset type 1 diabetes
NL-OMON49006Phase 2Completed
- Sponsor
- Diamyd Medical
- Start
- Apr 2019
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Diamyd, vitamin d in diabetes mellitus type 1 (T1D), sponsored by Diamyd Medical. Started Apr 2019; status: completed.
02
Drugs
Diamydvitamin d
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON49006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49006.